STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1%
Wed, 31 Jul

STRIDES PHARMA SCIENCE has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m6,6358,3976,858-18.3%3.4%
Other incomeRs m106146103-29.7%-3.7%
TurnoverRs m6,7418,5436,961-18.5%3.3%
ExpensesRs m5,8276,8085,649-17.0%-3.1%
Gross profitRs m7581,6791,143-31.9%50.7%
DepreciationRs m429438429-2.1%0.0%
InterestRs m441627353-43.6%-19.9%
Profit before taxRs m-5760463-39.1%
TaxRs m-4311131-71.8%
Profit after taxRs m38650432-33.5%1048.1%
Gross profit margin%11.420.016.7
Effective tax rate%837.314.56.7
Net profit margin%0.67.66.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 3.4% on a year-on-year (YoY) basis. The expenses were down by 3.1% YoY during the same period.
  • The company's operating profit increased by 50.7% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 16.7% in 1QFY20 as against 11.4% in 1QFY19.
  • Depreciation charges increased by 0.0% and finance costs declined by 19.9% YoY, respectively.
  • Other income declined by 3.7% YoY during the quarter.
  • Net profit for the quarter increased by 1048.1% YoY. Net profit margins during the quarter increased from 0.6% in 1QFY19 to 6.2% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 18.3% on a quarter-on-quarter (QoQ) basis. The expenses were down by 17.0% QoQ during the same period.
  • The company's operating profit declined by 31.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 16.7% in 1QFY20 as against 20.0% in 4QFY19.
  • Net profit for the quarter declined by 33.5% QoQ, while net profit margins declined from 7.6% in 4QFY19 to 6.2% in 1QFY20.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters,please visit here.

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year,STRIDES PHARMA SCIENCE share price has moved down from Rs 384.7 to Rs 374.7, registering a Loss of Rs 10.0 or around 2.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,557.7 (down 0.2%). Over the last one year it has moved down from 14,205.7 to 12,557.7, a gain of 1,648 points (down 11.6%).

Overall, the S&P BSE SENSEX is down 0.7% over the year.

Current Valuations

At the current price of Rs 374.7, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 15.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 0.9 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

This 20 Year Cycle Suggests Gold is Set for an August Rally(Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Aug 10, 2020 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 5-YR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS